A Randomized, Open Label, Phase III Trial to Evaluate the Efficacy and Safety of Palbociclib + AntiHER2 Therapy + Endocrine Therapy vs. AntiHER2 Therapy + Endocrine Therapy after Induction Treatment for Hormone Receptor Positive (HR+)/HER2Positive Metastatic Breast Cancer

  • White, Michelle (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date8/02/19 → 7/02/24